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CC BY-NC-ND license (http://creativBackground/Purpose: TRB3 (tribbles 3), an apoptosis-regulated gene, increases during endo-
plasmic reticulum stress. Hypoxia can induce inflammatory mediators and apoptosis in cardi-
omyocytes. However, the expression of TRB3 in cardiomyocyte apoptosis under hypoxia is
not thoroughly known. We investigated the regulation mechanism of TRB3 expression and
apoptosis induced by hypoxia in cardiomyocytes.
Methods: An in vivomodel of acute myocardial infarction (AMI) was applied in adult Wistar rats
to induce myocardial hypoxia. Rat neonatal cardiomyocytes were subjected to 2.5% O2 to
induce hypoxia.
Results: The expression of TRB3 was evaluated in cultured rat neonatal cardiomyocytes sub-
jected to hypoxia. Hypoxia significantly enhanced TRB3 protein and mRNA expression. Adding
c-jun N-terminal kinase (JNK) inhibitor SP600125, JNK small interfering RNA (siRNA), tumor ne-
crosis factor-a (TNF-a) antibody, and atorvastatin 30 minutes before hypoxia reversed the in-
duction of TRB3 protein. A gel-shift assay showed the DNA-binding activity of growth arrest and
DNA damage-inducible gene 153 (GADD153), which increased after hypoxia. Hypoxia
increased, whereas the TRB3-mut plasmid, SP600125, and TNF-a antibody abolished the
hypoxia-induced TRB3 promoter activity. Hypoxia increased the secretion of TNF-a fromave no conflicts of interest relevant to this article.
ardiology, Shin Kong Wu Ho-Su Memorial Hospital, 95 Wen-Chang Road, Taipei 111, Taiwan.
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acute myocardial infarction and
j.jfma.2016.07.010cardiomyocytes. Exogenous administration of TNF-a recombinant protein to the cardiomyo-
cytes without hypoxia increased TRB3 protein expression, similar to that observed after hyp-
oxia. Hypoxia-induced cardiomyocyte apoptosis is inhibited by TRB3 siRNA, the TNF-a
antibody, and atorvastatin. Atorvastatin reduced the TRB3 expression and cardiomyocyte
apoptosis induced by AMI. Hypoxia induces TRB3 through TNF-a, JNK, and the GADD153
pathway.
Conclusion: Treatment of atorvastatin inhibits the expression of TRB3 and cardiomyocyte
apoptosis induced by AMI and hypoxia.
Copyright ª 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Heart failure is a leading cause of mortality in Western
countries.1 The etiology of heart failure involves multiple
conditions, but cardiomyocyte apoptosis is one of the most
crucial pathogenic components.2 In recent years, there has
been a dramatic proliferation of studies on cardiomyocyte
apoptosis.3 At present, the role of cardiomyocyte apoptosis in
the progression of heart failure is not thoroughly understood.
Endoplasmic reticulum (ER) stress results in the unfolded
protein response (UPR), an adaptive response that pro-
motes organelle recovery.4 However, if ER stress is pro-
longed or UPR cannot restore homeostasis, UPR could
induce transcription factor growth arrest and DNA damage-
inducible gene 153 (GADD153) and activating transcription
factor 4 (ATF4), which regulate the expression of genes
involved in apoptosis.5 Tribble 3 (TRB3) (NM_175093), also
named neuronal cell deatheinducible putative protein ki-
nase, is an apoptosis-related gene during ER stress.6 TRB3 is
expressed in the liver, thymus, prostate, and heart.7 TRB3
expression was up-regulated under an in vitro model of
ischemiaereperfusion injury in cardiomyocytes.8 Experi-
mental acute myocardial infarction (AMI) significantly
increased TRB3 expression in murine heart tissue.9 Ohoka
et al noted that TRB3 is a novel target of GADD153 in the
TRB3 promoter.10 In addition, a previous study indicated
that GADD153 could activate TRB3.11 However, the role of
TRB3 in cardiomyocytes is still debated.
The ER-related apoptotic pathway was demonstrated to
be one of the mechanisms underlying AMI in car-
diomyocytes.12 Hypoxia could induce inflammatory media-
tors and apoptosis in cardiomyocytes.13 Tumor necrosis
factor-a (TNF-a) is known to trigger the inflammatory re-
action caused by ischemia and could induce cardiomyocytes
apoptosis.14 A previous study has indicated that treatment
with atorvastatin results in a significant reduction in the
levels of TNF-a.15 Atorvastatin, a 3-hydroxy-3-methylg-
lutaryl-coenzyme A (HMG-CoA) reductase inhibitor, is a
member of the statins used for treating hypercholesterole-
mia. Accumulated evidence demonstrates that atorvastatin
not only reduces the lipid level but also provides antiin-
flammatory and antiapoptotic benefits.16 However, the role
of atorvastatin in inflammation and oxidative stress caused
by hypoxia is not thoroughly understood. Therefore, the
central purpose of the present study was to investigate the
molecular mechanism of TRB3 under hypoxia inheng W-P, et al., Atorvastatin all
hypoxia, Journal of the Formcardiomyocytes. Moreover, we sought to determine the
possibility of using atorvastatin to inhibit the TRB3 expres-
sion and cardiomyocyte apoptosis under hypoxia and AMI.
Materials and methods
In vivo rat model of AMI
A rat model of the left anterior descending coronary artery
(LAD) occlusion was used in Wistar rats weighing 250e300 g
as described previously.17 Animals study protocols were
followed according to the Guide for the Care and Use of
Laboratory Animals (NIH publication No. 86e23, revised
2011) and were approved by the Committee of Animal Care
and Use at Shin Kong Wu Ho-Su Memorial Hospital (permit
number: 1021025015).
Cardiomyocytes primary culture
Cardiomyocytes were obtained from 2- to 3-day-old Wistar
rats by trypsinization as previously described.18 The obtained
cultured cardiomyocytes were >95% pure, as revealed by
observing contractile characteristics stained with an anti-
desmin antibody under a light microscope (Dako Cytomation,
Glostup, Denmark). Cardiomyocytes were seeded on a
cultureddish inHam’s F-10containing20% fetal bovine serum.
After 3 days in culture, cells were transferred to a serum-free
Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich
China Inc., Shanghai, China) and subjected to hypoxia.
Hypoxia apparatus
Hypoxic conditions (2.5% O2) were applied as described
previously.17 To investigate the roles of ERK (extracellular
signaleregulated kinase), p38, and JNK (c-Jun N-terminal
kinase) mitogen-activated protein kinases (MAPK) in the
protein expression of TRB3 induced by hypoxia, car-
diomyocytes were treated with PD98059 (50mM; Calbio-
chem, San Diego, CA, USA), SB203580 (3mM; Calbiochem), or
SP600125 (20mM) (Calbiochem) 30 minutes before hypoxia.
Reverse transcription polymerase chain reaction
Reverse transcription polymerase chain reaction was per-
formed as previously described.18eviates cardiomyocyte apoptosis by suppressing TRB3 induced by
osan Medical Association (2016), http://dx.doi.org/10.1016/
Atorvastatin alleviates cardiomyocyte apoptosis 3
+ MODELReal-time quantitative polymerase chain reaction
Real-time polymerase chain reaction was performed as pre-
viously described.18 The primers used were as follows: TRB3,
50-d(TCGCTGACCGTGAGAGGAA)-30 (forward) and 50-d(GCA
AGATGAGCCCGTGCTT)-30 (reverse); and glyderaldehyde-3-
phosphate dehydrogenase (GAPDH), 50-d(CATCACCATCT
TCCAGGAGC) (forward) and 50-d(GGATGATGTTCTGGGCT
GCC)-30 (reverse).
Western blot
Western blot was performed as previously described.18 The
antibodies used for Western blots were anti-TRB3 (1:200;
Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA); anti-
hypoxia inducible factor-1a (HIF-1a) (1:200; Santa Cruz
Biotechnology Inc.); and anti-TNF-a (1:1000, Bioss Inc.,
Woburn, MA, USA).
Electrophoretic mobility shift assay
Electrophoretic mobility shift assay (EMSA) was performed
as previously described.18 The GADD153 binding site used
was TGGTGCAATCCCC.18 The mutant oligonucleotides of
GADD153 sequences were TGGTATAATCCCC.
Construction of small interfering RNA
Cardiomyocytes were transfected with 800 ng of TRB3 small
interfering RNA (siRNA) (Dharmacon, Inc., Lafayette, CO,
USA). TRB3 siRNA: sense: 5ʹ-P.CAGCCUACCUCCCGCCUCA-3ʹ
and antisense: 5ʹ-P.UGAGGCGGGAGUAGGCUG-3ʹ. Scramble
siRNA of TRB3: sense: 5ʹ-P.UCCACCCGUUCGACCCACC-3ʹ and
antisense: 5ʹ-P.GGUGGGUCGAAC GGUGGA-3ʹ (Dharmacon).
JNK1 siRNA: sense: 5ʹ-P.CGUGGAUUUAUGGUCUGUGdTdT-3ʹ;
antisense: 5ʹ-P.CACAGACCAUAA AUCCACCdTdT-3ʹ
(Dharmacon).
Promoter activity assay
We used a low-pressure accelerated gene gun (Bioware
Technologies, Taipei, Taiwan) to transform the TRB3 pro-
moter construct containing the GADD153 binding site into
cardiomyocytes. The procedures were performed as previ-
ously described.18
Detection of TNF-a by enzyme-linked
immunosorbent assay
A conditioned medium from cardiomyocytes was subjected
to hypoxia and those from control (normoxia) cells were
collected for detection of TNF-a. The lowest limit of
detection of the TNF-a enzyme-linked immunosorbent
assay kit is 45 pg/mL.
Terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labeling assay
A Terminal deoxynucleotidyl transferase-mediated dUTP
nick-end labeling (TUNEL) assay was performed asPlease cite this article in press as: Cheng W-P, et al., Atorvastatin all
acute myocardial infarction and hypoxia, Journal of the Form
j.jfma.2016.07.010previously described.18 DNA fragmentation was determined
using the TUNEL assay with an ApopTag peroxidase in situ
apoptosis detection kit (Chemicon International, Temecula,
CA, USA). We then used a confocal microscope (Nikon D-
ECLIPSE; Nikon, Tokyo, Japan) and its associated image
processing/analysis software to obtain fluorescence signals.
Flow cytometric analysis for apoptosis
Cardiomyocytes stained with annexin V were determined to
be apoptotic cells. The procedures were performed as
previously described.18
Statistical analysis
All results are expressed as means  S.E.M. Statistical sig-
nificance was evaluated using analysis of variance (ANOVA)
(GraphPad Software, La Jolla, CA, USA). Dunnett’s test was
used to compare multiple groups with a single control
group. The TukeyeKramer comparison was used for pair-
wise comparisons between multiple groups after the
ANOVA; P< 0.05 was considered to denote statistical
significance.
Results
AMI increases the TRB3 protein and mRNA
expression in rat myocardia
The myocardial TRB3 protein expression significantly
increased in rats after AMI for 10 days (Figures 1A and 1B).
As shown in Figure 1C, real-time polymerase chain reaction
(PCR) demonstrated that TRB3 mRNA was up-regulated
after AMI. These results indicated that myocardial TRB3 is
induced by AMI in rat myocardia.
Atorvastatin reduces myocardial TRB3 protein
expression and apoptosis induced by AMI
As shown in Figures 2A and 2B, treatment with atorvastatin
significantly reversed the increase of TRB3 protein induced
by AMI. However, treatment with atorvastatin in the sham
group did not affect the myocardial TRB3 protein expres-
sion. As shown in Figure 2C and Figure S1A, atorvastatin
markedly inhibited the TUNEL positive cardiomyocytes
induced by AMI. These results demonstrated that atorvas-
tatin inhibits myocardial TRB3 protein expression and
apoptosis induced by AMI. Furthermore, treatment with
atorvastatin reduced the infarct size induced by AMI
(Figure S1B).
Hypoxia increases the protein and mRNA
expression of TRB3 in cultured cardiomyocytes
To test the effect of hypoxia on TRB3 expression, we used
different degrees of hypoxia (10%, 5%, and 2.5% O2) (Figures
S2A and S2B). TRB3 expression was observed to have the
most evident effect under 2.5% O2 hypoxia for 16 hours.
Thus, we applied 2.5% O2 as hypoxia in subsequent exper-
iments. As shown in Figures 3A and 3B, hypoxia markedlyeviates cardiomyocyte apoptosis by suppressing TRB3 induced by
osan Medical Association (2016), http://dx.doi.org/10.1016/
Figure 1 Effect of AMI on myocardial TRB3 protein levels and
mRNA. (A) Representative Western blots for TRB3 in rat myo-
cardia after AMI. (B) Quantitative analysis of TRB3 protein
levels. Values for myocardia after AMI were normalized to
match the a-tubulin measurement and then expressed as a
ratio of normalized values to protein in the control group
(n Z 3 per group). *P < 0.05 vs. control group. (C) Fold in-
creases in TRB3 mRNA as a result of induction of AMI. The
values for the experimental groups were normalized to match
the GADPH measurement and then expressed as a ratio of
normalized values to mRNA in the sham group. *P < 0.05 vs.
sham group (n Z 3 per group).
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levels of TRB3 mRNA also significantly increased from 8 to
16 hours after hypoxia treatment (Figure S2C). TRB3 siRNA
significantly attenuated the TRB3 protein expression
induced by hypoxia (Figures S3A and S3B).TRB3 protein expression induced by hypoxia in
cardiomyocytes is mediated by JNK
To investigate the possible signaling pathway mediating the
TRB3 induced by hypoxia in cardiomyocytes, the car-
diomyocytes were subjected to 2.5% O2 for 16 hours in the
presence or absence of inhibitors, siRNA and a vehicle
(DMSO 0.1%). As shown in Figure 3C and 3D, the hypoxia-
induced increases of TRB3 protein were significantlyPlease cite this article in press as: Cheng W-P, et al., Atorvastatin all
acute myocardial infarction and hypoxia, Journal of the Form
j.jfma.2016.07.010blocked after the addition of SP600125 (20mM) 30 min
before hypoxia. TRB3 protein induced by hypoxia were not
affected by the addition of SB203580 (3mM) or PD98059
(50mM). In addition, treatment of the JNK siRNA before
hypoxia significantly inhibited the TRB3 level induced by
hypoxia. The scramble siRNA and DMSO alone as a vehicle
control did not affect the hypoxia-induced TRB3 expres-
sion. Moreover, adding of atorvastatin (10mM) significantly
reversed the TRB3 protein expression induced by hypoxia
(Figures S3C and S3D). These results indicated that the JNK
pathway, but not ERK or p38 MAP kinases, mediates the
induction of TRB3 protein by hypoxia in cardiomyocytes.
Hypoxia increases GADD153 binding activity in
cardiomyocytes
As shown in Figure 4A, cardiomyocytes subjected to hypoxia
for 6 hours significantly increased the DNAeprotein-binding
activity of GADD153. An excess of unlabeled GADD153
oligonucleotide competed with the probe for binding
GADD153 protein, whereas an oligonucleotide containing a
2-bp substitution in the GADD153 binding site did not
compete for binding. Adding SP600125, JNK siRNA, TNF-a
Ab (5 mg/mL; R&D Systems, Minneapolis, MN, USA), and
atorvastatin before hypoxia significantly inhibited the
DNAeprotein-binding activity induced by hypoxia. Exoge-
nous administration of TNF-a to the cardiomyocytes
without hypoxia also increased the GADD153eDNA-binding
activity. However, the addition of the TNF-a antibody
abolished the increased binding activity induced by exog-
enous administration of TNF-a. These findings demonstrate
that hypoxia enhanced the GADD153 binding activity in
cardiomyocytes.
TRB3 promoter activity is induced by hypoxia
through GADD153
To determine whether the TRB3 expression induced by
hypoxia is regulated at the transcriptional level, we used a
luciferase reporter assay to identify the genetic transcrip-
tion activity of TRB3 in cardiomyocytes under hypoxia. The
TRB3 promoter construct contains an amino-acid response
element (AAREs), ATF4, and GADD153 binding sites
(Figure 4B). As shown in Figure 4C, hypoxia increased the
transcriptional activity of TRB3, but the TRB3 mutant failed
to exert the same effect. Moreover, adding the TNF-a
antibody, SP600125. and atorvastatin inhibited the tran-
scriptional activity of TRB3. These findings suggest that the
GADD153 binding site in the TRB3 promoter is essential for
transcriptional regulation in cardiomyocytes under hypoxia.
Hypoxia induces TRB3 protein expression in
cardiomyocytes through TNF-a
TNF-a secretion from cardiomyocytes under hypoxia
significantly increased at 2 hours and remained elevated for
16 hours (Figure 5A). Adding the TNF-a antibody or ator-
vastatin 30 minutes before hypoxia significantly inhibited
the expression of TNF-a induced by hypoxia. This result
demonstrated that hypoxia increases secretion of TNF-a
from cardiomyocytes.eviates cardiomyocyte apoptosis by suppressing TRB3 induced by
osan Medical Association (2016), http://dx.doi.org/10.1016/
Figure 2 Effect of AMI and treatment with atorvastatin (30 mg/kg daily) on myocardial TRB3 protein levels and apoptosis. (A)
Representative Western blots for TRB3 after induction of AMI with or without treatment with atorvastatin. (B) Quantitative analysis
of TRB3 protein levels. Values for myocardia after induction of AMI with or without treatment with atorvastatin. *P < 0.05 vs. sham
group (nZ 3 per group). (C) Representative microscopic images for rat myocardia after AMI or treatment of atorvastatin before AMI
then stained using a TUNEL kit. Blue indicates nuclei stained with DAPI. Red indicates desmin. Green indicates TUNEL positive
nuclei. Similar results were observed in other two independent experiments.
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expression in cardiomyocytes, TNF-a at different concen-
trations was added to the cultured medium for 16 h. As
shown in Figures 5B and 5C, the effect of TNF-a on TRB3
protein expression was dose-dependent. Adding the TNF-a
antibody 30 minutes before hypoxia markedly inhibited the
expression of hypoxia-induced TRB3. Furthermore, treat-
ment of atorvastatin abolished the expression of TRB3
protein induced by exogenous administration of TNF-a forPlease cite this article in press as: Cheng W-P, et al., Atorvastatin all
acute myocardial infarction and hypoxia, Journal of the Form
j.jfma.2016.07.01016 hours. These findings suggested that TNF-a mediates
TRB3 expression under hypoxia in cardiomyocytes.Hypoxia-induced cardiomyocyte apoptosis is
mediated by TRB3 and TNF-a
The TUNEL assay was performed to investigate the car-
diomyocyte apoptosis under hypoxia. A significant increaseeviates cardiomyocyte apoptosis by suppressing TRB3 induced by
osan Medical Association (2016), http://dx.doi.org/10.1016/
Figure 3 Effects of in vitro hypoxia and treatment with
MAPK inhibitors on TRB3 protein expression in cardiomyocytes.
(A) Representative Western blots for TRB3 in cardiomyocytes
after 2.5% O2 (hypoxia) treatment for various periods. (B)
Quantitative analysis of TRB3 protein levels. Values for car-
diomyocytes under hypoxia were normalized to match the a-
tubulin measurement and then expressed as a ratio of
normalized values to protein in the control group (n Z 3 per
group). *P < 0.05 vs. control. (C) Representative Western blots
for TRB3 protein levels in cardiomyocytes subjected to hypoxia
in the absence or presence of MAPK inhibitors, siRNA, and a
vehicle (DMSO 0.1%). (D) Quantitative analysis of TRB3 protein
levels. Values for cardiomyocytes under hypoxia were
normalized to match the a-tubulin measurement and then
expressed as a ratio of normalized values to protein in the
control group (n Z 3 per group). *P < 0.05 vs. control.
Figure 4 Effects of hypoxia on the GADD153-binding activity
and TRB3 promoter activity in cardiomyocytes. (A) Represen-
tative EMSA showing protein binding to a GADD153 oligonu-
cleotide in nuclear extracts of cardiomyocytes under hypoxia
during various periods and in the absence or presence of a JNK
inhibitor, siRNA, TNF-a antibody, and atorvastatin (10 mM).
Arrows indicate the mobility of the complex. Similar results
were found in another independent experiment. Cold oligo
means an unlabeled GADD153 oligonucleotide. (B) Constructs
of the TRB3 promoter gene. (C) Quantitative analysis of TRB3
promoter activity. Cardiomyocytes were transiently trans-
fected with pTRB3-luc by using a gene gun. The luciferase
activity in cell lysates was measured and normalized with
Renilla activity (nZ 3 per group). *P < 0.05 vs. TRB3 wild-type
control; **P< 0.05 vs. TRB3 wild-type for hypoxia 6 hours.
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16 hours (Figure 6A and Figure S4). The hypoxia-induced
TUNEL-positive nuclei of cardiomyocytes were signifi-
cantly inhibited by TRB3 siRNA, TNF-a Ab, and atorvastatin.
As shown in Figure 6B, apoptosis was determined through
propidium iodideeannexin V double staining and FACS
analysis. The percentage of cells stained with annexin V
was increased after hypoxia for 16 hours. Adding the TRB3
siRNA, TNF-a Ab, and atorvastatin before hypoxia signifi-
cantly reversed the percentage of annexin V-positive cellsPlease cite this article in press as: Cheng W-P, et al., Atorvastatin all
acute myocardial infarction and hypoxia, Journal of the Form
j.jfma.2016.07.010induced by hypoxia. These data demonstrated that car-
diomyocytes apoptosis induced by hypoxia is mediated by
TRB3 and TNF-a.Discussion
This paper presents the following significant results: (1)
in vitro hypoxia and in vivo AMI up-regulates TRB3 expres-
sion in cardiomyocytes; (2) JNK MAP kinase and the GADD153
transcription factor are involved in the signaling pathway of
TRB3 induction; (3) TRB3 expression in cardiomyocytes is
induced by hypoxia through TNF-a; (4) hypoxia enhancing
cardiomyocytes apoptosis is TRB3 dependent; and (5) ator-
vastatin inhibits TRB3 expression and apoptosis in car-
diomyocytes induced by hypoxia and AMI.
In the present study, we demonstrate that TRB3 mRNA
and protein expression in cardiomyocytes were up-
regulated under hypoxia. TRB3 expression induced byeviates cardiomyocyte apoptosis by suppressing TRB3 induced by
osan Medical Association (2016), http://dx.doi.org/10.1016/
Figure 5 Effects of rat TNF-a on TRB3 in cardiomyocytes. (A)
Release of rat TNF-a from cardiomyocytes subjected to hyp-
oxia for various periods of time (nZ 3 per group). *P < 0.05 vs.
control; **P < 0.05 vs. hypoxia for 4 hours. (B) Representative
Western blots for TRB3 in cardiomyocytes after exogenous
administration of TNF-a. (C) Quantitative analysis of TRB3
protein levels. Values for cardiomyocytes were normalized to
match the a-tubulin measurement and then expressed as a
ratio of normalized values to control cells (n Z 3 per group).
*P < 0.05 vs. control.
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that TRB3 expression in cardiomyocytes was induced by
cyclic stretch and in vivo volume overload.18 In addition,
Avery et al reported that TRB3 was induced in response to
an in vitromodel of ischemiaereperfusion injury for 4 hours
in HL-1 cardiomyocytes.8 However, it was demonstrated
that CoCl2, a chemical inducer of hypoxia, did not affect
the TRB3 expression in PC-3 cells.19 A partial explanation
for this may be that the cell was different. Another possible
explanation for this is the difference between physical and
chemical hypoxic stresses. Moreover, previous studies have
demonstrated that AMI can induce TRB3 expression in car-
diomyocytes.8,9 These observations are consistent with our
results regarding AMI-induced myocardial TRB3 expression.
Our data reveal that TRB3 protein expression induced by
hypoxia is mediated by JNK because the JNK inhibitor and
siRNA abolished the TRB3 expression. SP600125, a specific
inhibitor of JNK, inhibited the TRB3 expression induced by
hypoxia. However, inhibitors of ERK and p38 MAPK had no
inhibitory effect. Previously, we determined that TRB3
expression induced by cyclic stretch is mediated by JNK.17Please cite this article in press as: Cheng W-P, et al., Atorvastatin all
acute myocardial infarction and hypoxia, Journal of the Form
j.jfma.2016.07.010Furthermore, Humphrey et al have demonstrated that
TRB3 is required for optimal MLK3-JNK activation in
pancreatic beta cells.20 Adding SB203580 was demonstrated
as enhancing the expression of TRB3 in response to 4-
hydroxy-trans-2-nonenal (4-HNE) in PC12 cells.21 Further-
more, Zhang et al indicated that TRB3 may be involved in
diabetic nephropathy by regulating the collagen type IV
through the ERK1e2 MAPK pathway.22 These findings sug-
gest that TRB3 is closely linked with the MAPK signaling
pathway. In the present study, we demonstrated that
hypoxia-induced TRB3 expression acts via the GADD153
pathway. The TRB3 gene contains an AARE similar to
genomic elements that are responsive to activation by
GADD153.10 Bromati et al noted that GADD153 cooperates
with ATF4 to activate the TRB3 gene.23 In addition, a study
indicated that hypoxia-induced TRIB3 is regulated by the
GADD153 pathway of the UPR.24 These findings are consis-
tent with our results.
In this study, we provide the first evidence that TRB3
protein expression in cardiomyocytes is induced by hypoxia
through TNF-a. Ord et al demonstrated that TRB3 is regu-
lated by IL-3 in mouse bone marrowederived mast cells.25
In addition, it has been revealed that induction of TRB3 in
hepatocytes is induced by IFN-gamma.26 These studies
complement each other because each has emphasized a
different aspect of experimental model or cells. Notably,
Steverson et al indicated that TRB3 overexpression sup-
pressed inflammation by reduced expression and secretion
of TNF-a.27 In another study, knockdown of TRB3 by siRNA
significantly induced the production of TNF-a in RBL-CCR1
cells.28 These results suggest a feedback relationship be-
tween TRB3 and TNF-a.
Hypoxia-induced cardiomyocyte apoptosis is regulated
by TRB3. Wang et al have suggested that TRB3 mediates
renal tubular-cell apoptosis induced by protein overload.29
A previous study demonstrated that TRB3 was involved in
lipoapoptosis of INS-1 b cells.30 Moreover, TRB3 was re-
ported to be a crucial mediator of palmitate-induced
apoptosis in human liver cells.31 The findings of these
studies are consistent with our data that TRB3 was involved
in apoptosis. By contrast, a study indicated that TRB3
contributes to the survival and activity of primary cultured-
mast cells.25 Furthermore, Zhou et al demonstrated that
knocking down TRB3 significantly induced lung-cancer cell
apoptosis.32 These findings implicate that TRB3 plays a
crucial role in not only cell death but also survival. In
general, the characteristic of TRB3 is injurious rather than
protective.
In this study, we demonstrated that atorvastatin inhibits
TRB3 expression and apoptosis induced by hypoxia and AMI
in cardiomyocytes. A previous study demonstrated that
atorvastatin protects cardiomyocyte H9C2 from oxidative
stress through the inhibition of lectin-like oxidized low-
density lipoprotein receptor-1 and apoptosis.33 Abdel-
Hamid et al also suggested that atorvastatin could pre-
serve myocardial structure in diabetic cardiomyopathy by
suppressing cardiomyocyte apoptosis and oxidative stress.34
These results indicate that atorvastatin has heart-
protective effects from oxidative stress. The findings of
our study indicate that TNF-a induced by hypoxia is
inhibited by atorvastatin. Moreover, it has been implicated
that treatment with atorvastatin can reduce TNF-a ineviates cardiomyocyte apoptosis by suppressing TRB3 induced by
osan Medical Association (2016), http://dx.doi.org/10.1016/
Figure 6 Effects of TRB3 on hypoxia-induced apoptosis in cardiomyocytes. (A) A TUNEL assay was used to detect the car-
diomyocyte apoptosis after hypoxia. Blue indicates nuclei stained with DAPI. Red indicates the cytoskeleton stained with rhoda-
mine. Green indicates TUNEL-positive nuclei. Representative microscopic images of cardiomyocytes after hypoxia for 16 hours,
addition of TNF-a Ab, TRB3 siRNA, or atorvastatin before hypoxia, then stained using the TUNEL kit. Similar results were observed
in other two independent experiments. (B) Cardiomyocytes were subjected to hypoxia for 16 hours, TNF-a Ab, TRB3 siRNA, or
atorvastatin (10 mM) was added before hypoxia. Quantification of the apoptotic fractions was performed using FACScan. Cells that
stained negative for both Annexin V and PI were alive. Cells that stained positive for Annexin V and negative for PI were undergoing
apoptosis. Cells that stained positive for both Annexin V and PI were at the end stage of apoptosis called second apoptosis (nZ 3).
*P < 0.05 vs. control; **P < 0.05 vs. hypoxia for 16 hours.
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+ MODELischemic heart-failure patients.15 Moreover, Dai et al
demonstrated that atorvastatin inhibits the production of
TNF-a after hypoxia or AMI.35 The findings of these studies
are consistent with our results. We found that atorvastatinPlease cite this article in press as: Cheng W-P, et al., Atorvastatin all
acute myocardial infarction and hypoxia, Journal of the Form
j.jfma.2016.07.010can abrogate the GADD153 binding activity induced by
hypoxia. By contrast, Sun et al indicated that atorvastatin
can enhance levels of nuclear factor erythroid 2-related
factor 2 to alleviate oxidative stress induced byeviates cardiomyocyte apoptosis by suppressing TRB3 induced by
osan Medical Association (2016), http://dx.doi.org/10.1016/
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vastatin can be considered a nonlipid-lowering benefit of
statins to improve oxidative stress disease.
We found protein expression of HIF-1a is induced by
hypoxia (Figures S5A and S5B). A previous study demon-
strated that hypoxia can increase the expression of HIF-1a
in cardiomyocyte H9C2.
36 Treatment of atorvastatin before
hypoxia significantly inhibited the protein expression of
HIF-1a induced by hypoxia (Figures S5C and S5D). In addi-
tion, adding the HIF-1a siRNA before hypoxia did not have a
significant effect on the TRB3 and TNF-a protein expression
induced by hypoxia (Figure S6). Wennemers et al indicated
that knockdown of HIF-1a did not alter the anoxia induction
of TRB3 expression in breast cell lines.24 These results
suggest TRB3 expression induced by hypoxia is HIF-1a
independent.
In summary, our study reports that hypoxia induces TRB3
expression in rat cardiomyocytes. Hypoxia induces TRB3
through TNF-a, JNK MAPK, and the GADD153 pathway.
Treatment of atorvastatin inhibits the TRB3 expression and
cardiomyocyte apoptosis induced by hypoxia and AMI. This
study concludes that atorvastatin can alleviate car-
diomyocyte apoptosis by inhibiting TRB3 induced by hyp-
oxia and AMI. The findings of this study may contribute
toward a clearer understanding of the role of TRB3 under
ischemia in cardiomyocytes.
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